Replies to post #5924 on Skye Bioscience Inc (SKYE)

[frozenspokes]

Show me where they say Clinical Trials begin in 3 months. I would be ecstatic for that news. The Company Update reads Q32021.

Agree on all your opinions of the awfulness of a reverse split. It would ruin existing shareholders like me who have been in this for years.

I'm very familiar with the regs and requirements for uplisting on all exchanges. Anyone who plays in the OTC market should be intimately familiar with the multiple liquidity, reporting and financial requirements to uplist...

They actually filed an application with NYSE to uplist in 2015 (that went nowhere), a year after they executed the reverse merger to the OTC while they were still Nemus (NMUS) after their series B round. Mainly because NASDAQ is more strict + $4 share price requirement.